Thank you for the great article - and just FYI, similar to the FDA failing to approve the testosterone patch for women, they also recently decided to reject Bremelanotide - one of the experimental treatments for FSAD you mentioned.
However, the company that was developing Bremelanotide (Palatin Technologies) is now starting tests on a new drug that works similarly in creating arousal in women and men - but without the minor side effect of increased blood pressure in a few people - that's called "PL-6983".
I made my name in this comment link to a post on the Bremelanotide Bulletin that discusses this most recent development, in case you or your readers are interested.
Comment Reply
Hi,
Thank you for the great article - and just FYI, similar to the FDA failing to approve the testosterone patch for women, they also recently decided to reject Bremelanotide - one of the experimental treatments for FSAD you mentioned.
However, the company that was developing Bremelanotide (Palatin Technologies) is now starting tests on a new drug that works similarly in creating arousal in women and men - but without the minor side effect of increased blood pressure in a few people - that's called "PL-6983".
I made my name in this comment link to a post on the Bremelanotide Bulletin that discusses this most recent development, in case you or your readers are interested.
Thanks!
// Claire.
August 2, 2008 - 10:42pmThis Comment
Reply